Northcape Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Northcape Wealth Management's LLY Position: Q2 2026 in Review
Northcape Wealth Management reduced its Eli Lilly (LLY) stake by 0.82% in Q2 2026, selling an estimated $38.8K and leaving 4,618 shares worth $5.54M. The position accounts for 1.45% of the portfolio, ranked #16.
Northcape Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.49M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Northcape Wealth Management held 4,618 shares of Eli Lilly worth $5.54M as of Q2 2026.
- Northcape Wealth Management sold 38 Eli Lilly shares in Q2 2026, an estimated $38.8K.
- Eli Lilly made up 1.45% of Northcape Wealth Management's portfolio in Q2 2026, its #16 holding.
- Northcape Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Northcape Wealth Management's Eli Lilly position peaked at $6.49M in Q2 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Northcape Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.